EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Rapid assessment of direct oral anticoagulants in acute stroke—An educational systematic review

Joshua Mbroh iD, Ingvild Birschmann, Matthias Ebner, Johanna A Kremer Hovinga, Edelgard Lindhoff-Last, Jan Purrucker, Simon T Schäfer, Johannes Tünnerhoff, Yi Wang, Sven Poli iD

European Stroke Journal · 2025

DOI: 10.1177/23969873241310359 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Stroke Journal, 2025. Verfasst von Joshua Mbroh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology & Stroke, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Anticoagulants, Point-of-Care Testing, Stroke. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To provide an overview on commercially available point-of-care tests (POCT) for rapid assessment of direct oral anticoagulant (DOAC) activity, their diagnostic accuracy in identifying blood samples containing clinically relevant DOAC concentrations, and guidance on selecting the appropriate POCT system/assay for decision-making in emergencies.

Methods

Systematic review with PubMed and Cochrane library search for published studies until September 6, 2024. Papers were included if in English, original research using blood samples from DOAC patients and POCT was implemented. Two reviewers assessed studies for eligibility and quality. Data from studies were aggregated and diagnostic accuracy at DOAC plasma thresholds of 30/50/100 ng/ml was recalculated.

Findings

16 studies involving four commercially available POCT systems/assays were identified. Eleven studies evaluated blood-based POCT and five used urine for indirect estimation of DOAC plasma levels.

Discussion

DOAC Dipsticks do not require knowledge about the taken DOAC, but measure urine and, due to low specificity, require blood testing in case of positive results. Hemochron Signature Elite (HSE) and CoaguChek use global coagulation assays and provide high sensitivity for edoxaban and rivaroxaban, HSE additionally for dabigatran. Due to insufficient correlation, both POCT are not recommended for apixaban, CoaguChek also not for dabigatran. The thromboelastometric ClotPro performs well for all DOAC, does not require knowledge about the DOAC, but was taken off the market recently.

Conclusion

Studies have shown feasibility of POCT in identifying blood samples containing clinically relevant DOAC plasma concentrations. Each POCT device has its own unique limitations. Knowledge about the POCT assays, time since last intake and type of DOAC enhances confidence in making appropriate therapeutic decisions. We propose an algorithm that could help guiding physicians in selecting an appropriate POCT system/assay in DOAC-related emergencies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsPoint-of-Care TestingStrokeHumansAdministration, OralRivaroxabanPoint-of-Care SystemsBlood Coagulation Tests

Stichwörter der Autor:innen

DOACNOACPOCTdirect oral anticoagulantsnon-vitamin K antagonist oral anticoagulantspoint-of-care test

Substanzen

AnticoagulantsRivaroxaban

Autor:innen und Institutionen

  • Department of Neurology & Stroke, University of Tübingen, Tübingen, Germany.
  • Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • Institute for Laboratory and Transfusion Medicine, Heart and Diabetes Center, Ruhr University, Bad Oeynhausen, Germany.
  • Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Berlin, Germany.
  • Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner site Berlin, Berlin, Germany.

ORCID-Profile: Joshua Mbroh, Sven Poli

Zitieren

APA

Mbroh, J., Birschmann, I., Ebner, M., Kremer Hovinga, J. A., Lindhoff-Last, E., Purrucker, J., Schäfer, S. T., Tünnerhoff, J., Wang, Y., & Poli, S. (2025). Rapid assessment of direct oral anticoagulants in acute stroke—An educational systematic review. European Stroke Journal. https://doi.org/10.1177/23969873241310359

Vancouver

Mbroh J, Birschmann I, Ebner M, Kremer Hovinga JA, Lindhoff-Last E, Purrucker J, et al. Rapid assessment of direct oral anticoagulants in acute stroke—An educational systematic review. European Stroke Journal. 2025. doi:10.1177/23969873241310359

BibTeX
@article{Mbroh2025,
  author = {Mbroh, Joshua and Birschmann, Ingvild and Ebner, Matthias and Kremer Hovinga, Johanna A and Lindhoff-Last, Edelgard and Purrucker, Jan and Schäfer, Simon T and Tünnerhoff, Johannes and Wang, Yi and Poli, Sven},
  title = {Rapid assessment of direct oral anticoagulants in acute stroke—An educational systematic review},
  journal = {European Stroke Journal},
  year = {2025},
  doi = {10.1177/23969873241310359}
}
Kostenlos starten →